Haleon Participates in CIIE for Five Consecutive Years, Sharing Innovation Opportunities to Support High-Quality Economic Growth in China

ShanghaiOctober 8, 2023PR Newswire -- The 6th China International Import Expo (hereinafter referred to as "CIIE") is set to grandly open on November 5, 2023. Haleon, a multinational consumer health company with well-known brands such as Caltrate, Centrum, Sensodyne, Panadol, Contac, Bactroban, Voltaren, Flixonase, and Polident, has announced its participation in the 6th CIIE. Previously part of the consumer healthcare division of GlaxoSmithKline, Haleon participated in three consecutive editions of the CIIE. This year marks the second time Haleon will attend the CIIE as an independent company following its spin-off from GlaxoSmithKline in 2022.

Design of Haleon Booth at the 6th CIIE

At this year's CIIE, Haleon will appear at the Medical Devices and Healthcare Products Exhibition Area (8.1H), creating a "Daily Health Community" scenario and presenting comprehensive daily health solutions covering the entire life cycle. Haleon will focus onShow Nearby40 Star Products, includingMore than ten products making their global or China debut,Covering five major categories: nutritional health, oral health, pain management, respiratory health, and skin health. Meanwhile, Haleon will launch its world's first customized nutrition platform during the CIIE.Keyi Home, providing consumers with customized nutritional enhancement solutions. As a strong testament to its mission of "people-centric, improving daily health," Haleon will also introduce its health education projects at the event — "Bone Health China," "Pain-Free China," and "Strong Teeth China" — developed in collaboration with authoritative institutions, experts, scholars, and industry partners, sharing its latest achievements in advancing "health accessibility and equity."

China is one of the most important markets for Haleon globally. Many well-known brands under Haleon have served Chinese consumers for over thirty years. Among multinational companies, its over-the-counter (OTC) medicines and nutritional health products businesses rank first in offline retail pharmacy channels [1]. In 2022, Haleon performed exceptionally well globally, achieving annual sales of £10.9 billion and 9% organic growth. In the first half of 2023, Haleon also delivered impressive results, achieving 10.4% organic growth globally. The performance in the Chinese market was particularly outstanding, making a significant contribution to the company’s overall growth in both global and Asia-Pacific regions.

The CIIE is a significant achievement of China's expanded opening-up, providing a platform for win-win cooperation for global enterprises. Haleon has always regarded the CIIE as an important platform to understand the latest demands of Chinese consumers, obtain first-hand product feedback from the consumer end, and transform exhibits into future best-selling products. It also further participates in interactive exchanges among ecosystem partners, promoting high-quality and sustainable development of the health industry, and jointly advancing the further enhancement and leap forward of China’s society and economy. Haleon looks forward to progressing together with China’s health industry in the future, contributing to the realization of the wonderful vision of ‘Healthy China’, and making even more outstanding contributions to economic growth in China’s health sector.

[1]   According to the IQVIA China Retail Pharmacy Statistical Report, Q4 2022 MAT sales revenue ranking, Haleon ranked first among multinational companies in China's offline retail over-the-counter (OTC) drug market and nutritional health products market.

About Haleon

Haleon (LSE/NYSE: HLN) aims to become a global leader in the consumer health sector, fulfilling its corporate mission of "Putting People First, Improving Daily Health." Haleon's product portfolio covers five major categories: oral health, pain management, respiratory health, digestive health, and nutritional health. By combining trusted science with an understanding of human health, Haleon has created well-known brands, including Caltrate, Centrum, Sensodyne, Panadol, Voltaren, Contac, Bactroban, Flixonase, and Polident.

For more information, please refer towww.haleon.com